Table 2.
Pathology information for the 28 samples
Case | PR/CR | Tumour type | TNM Staging |
---|---|---|---|
1 |
PR |
Undifferentiated squamous cell carcinoma |
T3NxMx |
2 |
PR |
Undifferentiated cell carcinoma WHO type III |
T3N3Mx |
3 |
PR |
Moderately differentiated squamous cell carcinoma |
T3N3Mx |
4 |
PR |
Undifferentiated Carcinoma |
T3N3Mx |
5 |
PR |
Infiltrating, non-keratinising undifferentiated carcinoma; Loc adv NPC T1-2N2Mx with neck node mets, residual lesion |
T3N3Mx |
6 |
PR |
Undifferentiated carcinoma ; CA nasopharynx stage III |
T3N1Mx |
7 |
PR |
Moderately differentiated squamous cell carcinoma, keratinizing, NPC with Extensive right neck node mets; Residual disease and neck node; stable disease liver lesion |
T2N3Mx |
8 |
PR |
Undifferentiated carcinoma WHO-3 , infiltrating |
T2N1Mx |
9 |
PR |
Undifferentiated carcinoma WHO - 3, infiltrating; Loc adv NPC with neck node mets and multiple cranial nerces invol |
T4N3Mx |
10 |
PR |
Undifferentiated carcinoma |
T2N3Mx |
11 |
PR |
Poorly differentiated carcinoma |
T2N?Mx |
12 |
PR |
Infiltrating, non-keratinizing undifferentiating carcinoma WHO type III tumour |
T2N1Mx |
13 |
PR |
Poorly differentiated or anaplastic carcinoma |
T2N1Mx |
14 |
CR |
Invasive, non-keratinising undifferentiated carcinoma WHO type III tumour |
T3N2Mx |
15 |
CR |
Undifferentiated carcinoma, infiltrating; carcinoma of the nasopharynx, tumour involving the sphenoid bone & extending into the sphenoid sinus. |
T4N2Mx |
16 |
CR |
Undifferentiated carcinoma |
T2N2Mx |
17 |
CR |
Undifferentiated carcinoma, infiltrating, non-keratinizing WHO type III; Undiff NPC with retropharyngeal and left internal post jugular lymphadenopathy, for restaging. |
T3N3Mx |
18 |
CR |
Undifferentiated carcinoma; Loc adv NPC T3N0Mx extending to the left parapharyngeal region |
T3N0Mx |
19 |
CR |
Undifferentiated carcinoma |
T4N1Mx |
20 |
CR |
Undifferentiated carcinoma |
T3N1Mx |
21 |
CR |
Undifferentiated carcinoma (with left vocal cord palsy) |
T3N2Mx |
22 |
CR |
Undifferentiated carcinoma (with cervical node metastases); NPC with neck node mets |
T3N2Mx |
23 |
CR |
Undifferentiated carcinoma |
T3N2Mx |
24 |
CR |
Non-keratinizing undifferentiated carcinoma, WHO type III, restaging |
T2N1Mx |
25 |
CR |
Undifferentiated carcinoma; CT scan - neck node |
T2N1Mx |
26 |
CR |
Undifferentiated carcinoma; Loc adv carcinoma of the nasopharynx with neck node mets, extension to parapharyngeal region right more than left and involvement of the ptergoid muscles |
T3N2Mx |
27 |
CR |
Infiltrating non keratinising undifferentiated carcinoma; Tumour involv. Both FOR with parapharyngeal & rectopharyngeal extension |
T3N1Mx |
28 | CR | Undifferentiated carcinoma; loc adv T4N1Mx. Tumour involv PNS, clivus, paratracheal & prevertebral muscles, ant nasal cavity and ext to both middle cranial fossa (extradural mass) | T4N1Mx |